COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04760821


Column Value
Trial registration number NCT04760821
Full text link
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Luis Henrique Wolff Gowdak, MD, PhD

Contact
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

luis.gowdak@gmail.com

Registration date
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2021-02-18

Recruitment status
Last imported at : Feb. 3, 2023, 8 p.m.
Source : ClinicalTrials.gov

Unknown

Study design
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

a. inclusion criteria: clinical diagnosis of moderate to severe acute respiratory syndrome due to sars-cov2 defined as: 1.1. tachypnea: > 24 breaths per minute 1.2. hypoxemia: arterial oxygen saturation <94% in room air by pulse oximetry 1.3. presumptive (or confirmed) diagnosis of sars-cov2 infection by at least one of the following criteria: polymerase chain reaction assay (+) for sars-cov2 serology (+) for sars-cov2 sars-cov2 antigen diagnostic tests (+) chest ct with findings suggestive of the diagnosis of covid-19 in the presence of medical history or clinical signs compatible with the diagnosis of covid-19 signature of the informed consent form b.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

chronic renal dysfunction stage 4 (gfr <30ml / min / 1.73m2 calculated by the chronic kidney disease epidemiology collaboration (ckd-epi) equation patient on renal replacement therapy by dialysis pregnant and lactating women previous use of trimetazidine less than two weeks before hospital admission any clinical condition at the investigator“s discretion likely to be associated with elevation of baseline hs-troponin >99th percentile

Number of arms
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Ministry of Health, Brazil

Inclusion age min
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Brazil

Type of patients
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

80

primary outcome
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

High-sensitivity cardiac troponin

Notes
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : Feb. 20, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "", "treatment_id": 1318, "treatment_name": "Trimetazidine", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}]